Effect of tibolone on the survival of early stage cervical adenocarcinoma patients.

Seung-Ho LeeYoon-Jin ChoKyung-Joo ChoMee-Hyang KoSun-Young JungSeung-Joo ChonSo-Yi LimKwang Beom Lee

Published in: Obstetrics & gynecology science (2018)

Tibolone has no adverse effect on the survival of cervical AC patients and can be administered safely to this population. These findings may be helpful in improving the quality of life of cervical AC patients.

Keyphrases

end stage renal disease
early stage
ejection fraction
newly diagnosed
squamous cell carcinoma
prognostic factors
patient reported outcomes
electronic health record